Medical Marijuana

Report: Medical Marijuana & Palliative Care—Prescriber & Patient Perspectives

Download the report or watch the recording presented by Daniel S. Fitzgerald, CEO, and Meghan Oates-Zalesky, CMO, of Apollo Intelligence. 

In 2018, less than a third of US oncologists believed they were informed enough to make recommendations to patients regarding medical marijuana, according to a study conducted by the Journal of Clinical Oncology. Five years later, the Apollo team wanted to understand if prescriber confidence had grown and how patients with chronic pain perceived medical marijuana as a palliative alternative.

  • The adoption of medical marijuana across the U.S. and Europe
  • The considerations affecting patients as they address chronic pain management and the options available to them
  • Physicians’ positions on prescribing medical marijuana for palliative treatment

Get the Report

You may also be interested in:

AI Marketing: Four Takeaways from Konovo’s Rebrand

As Konovo prepared for its 2025 rebrand, the team embraced the energy around AI but wanted to ground the storytelling in responsible marketing—staying close to what the platform’s AI can...
Keep Reading
pills

Inside the Cash-to-Care Movement: Early Insights from Clinicians

Starting in January 2026, patients can use HSAs for Direct Primary Care, speeding the shift toward cash-pay, consumer-driven healthcare. Clinicians expect greater autonomy and changing prescribing patterns, along with new...
Keep Reading

Nurses Warn New Federal Policy Could Deepen Workforce Strains and Limit Patient Access

New feedback from nurses shows strong concern that reclassifying advanced nursing degrees, and limiting federal funding—will intensify workforce shortages, increase financial barriers to education, and ultimately affect patient care....
Keep Reading